Media

In a new white paper issued today, BIO updates the results of a study of the greenhouse gas emissions resulting from EPA's proposal to reduce biofuel use...
BIO is pleased to announce the creation of the BIO Rosalind Franklin Award for Leadership in Industrial Biotechnology to be presented to an outstanding...

Press Releases

Jul 2 1999
(WASHINGTON, D.C., July 2, 1999) The Biotechnology Industry Organization (BIO) today praised U.S. Rep. Jennifer Dunn (R-Wash.) for introducing a House bill (H....
Jul 1 1999
WASHINGTON, D.C. (July 1, 1998) - At its annual membership meeting June 16, 1998 in New York City, the Biotechnology Industry Organization (BIO) elected 13...
Jun 30 1999
WASHINGTON, DC (June 30, 1999) -- The American Hospital Association and the Biotechnology Industry Organization (BIO) have signed a memorandum of...
Jun 29 1999
(WASHINGTON, D.C., June 29, 1999) Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement in response to...
Jun 26 1999
(WASHINGTON, D.C., JUNE 26, 1999)--Anticipating President Clinton's announcement of a plan for a drug benefit for the nation's medicare program this...
Jun 22 1999
WASHINGTON, D.C. (June 22, 1999) The Senate Finance Committee will hold a hearing Wednesday, June 23, 1999, at 10 a.m. to discuss Medicare and prescription...
May 26 1999
SEATTLE, WASHINGTON MAY 17, 1999 Ladies and Gentlemen: I've entitled this talk, "With the 20th Century in Our Rear View Mirror, The Choices...
May 19 1999
SEATTLE, Washington, (May 19, 1999) Dr. Thomas Dooley, presiding officer and co-founder of the Biotechnology Association of Alabama (BAA), received the...
May 19 1999
WASHINGTON, D.C. (May 19, 1999) - BIO Vice President of Food & Agriculture L. Val Giddings, Ph.D. released the following statement in response to...


Biotechnology News

October 30, 2014

DOYLESTOWN, Pa.--(BUSINESS WIRE)--Marcum LLP and Philadelphia SmartCEO recognized the area’s top leaders in innovation at the 2014 Marcum Innovator of the Year Awards,...

October 30, 2014

BOSTON--(BUSINESS WIRE)--The Joslin Institute for Technology Translation (JITT) announces that three Johnson & Johnson Diabetes Solutions Companies have joined JITT as...

October 30, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter presented the results of a Phase 2/3 study of its investigational 20 percent concentration subcutaneous immunoglobulin treatment...

October 30, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Phase 2 Objective Response Rate&Survival Data for Opdivo(nivolumab) in Heavily Pre-treated Advanced Squamous Cell Non-Small Cell Lung...

October 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ:GNCA), a clinical-stage biopharmaceutical company developing T cell-directed vaccines and...